Suppr超能文献

儿童脓毒症的抗菌治疗:最佳策略是什么?

Antimicrobial Therapy in Pediatric Sepsis: What Is the Best Strategy?

作者信息

Mau Luciana Becker, Bain Vera

机构信息

Department of Hospital Epidemiology and Infection Control, Hospital Municipal Infantil Menino Jesus, São Paulo, Brazil.

Pediatric Infectious Diseases Unit, Hospital das Clínicas, Instituto da Criança, Universidade de São Paulo (HC-FMUSP), São Paulo, Brazil.

出版信息

Front Pediatr. 2022 Feb 15;10:830276. doi: 10.3389/fped.2022.830276. eCollection 2022.

Abstract

Pediatric sepsis is a relevant cause of morbidity and mortality in this age group. Children are affected differently in high and low-income countries. Antibiotics are crucial for the treatment of sepsis, but indiscriminate use can increase resistance worldwide. The choice of a correct empiric therapy takes into consideration the site of infection, local epidemiology, host comorbidities and recent antibiotic exposure. Antibiotics should be administered in the first hour for patients with septic shock, and always intravenously or intraosseous access. Culture results and clinical improvement will guide de-escalation and length of treatment. New diagnostic methods can help improve the prescription of adequate treatment. Prevention of sepsis includes vaccination and prevention of healthcare-associated infections. More research and education for awareness of sepsis is needed to improve care.

摘要

小儿脓毒症是该年龄组发病和死亡的一个相关原因。高收入和低收入国家的儿童受到的影响有所不同。抗生素对于脓毒症的治疗至关重要,但不加区分地使用会增加全球范围内的耐药性。正确的经验性治疗选择需考虑感染部位、当地流行病学情况、宿主合并症以及近期抗生素使用情况。对于感染性休克患者,应在第一小时内给予抗生素,且始终通过静脉或骨内途径给药。培养结果和临床改善情况将指导降阶梯治疗和治疗时长。新的诊断方法有助于改进适当治疗的处方。脓毒症的预防包括接种疫苗和预防医疗保健相关感染。需要开展更多研究并进行脓毒症相关教育以提高护理水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af9f/8885802/8d6688e68915/fped-10-830276-g0001.jpg

相似文献

1
Antimicrobial Therapy in Pediatric Sepsis: What Is the Best Strategy?
Front Pediatr. 2022 Feb 15;10:830276. doi: 10.3389/fped.2022.830276. eCollection 2022.
2
Sepsis Care Pathway 2019.
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.
4
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.
Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af.
6
De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock.
Cochrane Database Syst Rev. 2010 Dec 8(12):CD007934. doi: 10.1002/14651858.CD007934.pub2.
7
De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock.
Intensive Care Med. 2014 Jan;40(1):32-40. doi: 10.1007/s00134-013-3077-7. Epub 2013 Sep 12.
8
Sepsis and septic shock: selection of empiric antimicrobial therapy.
Crit Care Clin. 2008 Apr;24(2):313-34, ix. doi: 10.1016/j.ccc.2007.12.015.
9
The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
Surg Infect (Larchmt). 2013 Dec;14(6):489-511. doi: 10.1089/sur.2012.028. Epub 2013 Nov 25.

引用本文的文献

1
How to manage delayed high-grade kidney trauma on pediatric and its complications: A case report.
Int J Surg Case Rep. 2025 Mar;128:111067. doi: 10.1016/j.ijscr.2025.111067. Epub 2025 Feb 17.
3
Ceftriaxone Pharmacokinetics and Pharmacodynamic Target Attainment for Three Pediatric Patients Receiving Continuous Kidney Replacement Therapy.
J Pediatr Pharmacol Ther. 2024 Apr;29(2):180-187. doi: 10.5863/1551-6776-29.2.180. Epub 2024 Apr 8.

本文引用的文献

2
Antibiotic Stewardship in Pediatrics.
Pediatrics. 2021 Jan;147(1). doi: 10.1542/peds.2020-040295.
3
Optimizing the Use of Antibiotic Agents in the Pediatric Intensive Care Unit: A Narrative Review.
Paediatr Drugs. 2021 Jan;23(1):39-53. doi: 10.1007/s40272-020-00426-y. Epub 2020 Nov 10.
5
Culture-negative sepsis.
Curr Opin Crit Care. 2020 Oct;26(5):473-477. doi: 10.1097/MCC.0000000000000751.
6
Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance.
J Infect Dis. 2020 Jul 21;222(Suppl 2):S119-S131. doi: 10.1093/infdis/jiaa221.
7
Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review.
J Infect Dis. 2020 Jul 21;222(Suppl 2):S132-S141. doi: 10.1093/infdis/jiaa118.
8
Risk Factors for Subsequential Carbapenem-Resistant Clinical Infection Among Rectal Carriers with Carbapenem-Resistant .
Infect Drug Resist. 2020 May 5;13:1299-1305. doi: 10.2147/IDR.S247101. eCollection 2020.
10
"Rationalization of Empiric Antibiotic Therapy" - A Move Towards Preventing Emergence of Resistant Infections.
Indian J Pediatr. 2020 Nov;87(11):945-950. doi: 10.1007/s12098-019-03144-7. Epub 2020 Jan 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验